Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins.
The mammalian APOBEC3 family of cytidine deaminases includes members that can act as potent inhibitors of retroviral infectivity and retrotransposon mobility. Here, we have examined whether the alpharetrovirus Rous sarcoma virus (RSV) is susceptible to inhibition by a range of human APOBEC3 proteins. We report that RSV is highly susceptible to inhibition by human APOBEC3G, APOBEC3F, and APOBEC3B and moderately susceptible to inhibition by human APOBEC3C and APOBEC3A. For all five proteins, inhibition of RSV infectivity was associated with selective virion incorporation and with C-to-T editing of the proviral DNA minus strand. In the case of APOBEC3G, editing appeared to be critical for effective inhibition. These data represent the first report of inhibition of retroviral infectivity and induction of proviral DNA editing by human APOBEC3A and reveal that alpharetroviruses, which do not normally encounter APOBEC3 proteins in their avian hosts, are susceptible to inhibition by all human APOBEC3 proteins tested. These data further suggest that the resistance of mammalian retroviruses to inhibition by the APOBEC3 proteins expressed in their normal host species is likely to have evolved subsequent to the appearance of this family of mammalian antiretroviral proteins some 35 million years ago; i.e., the base state of a naïve retrovirus is susceptibility to inhibition.
Wiegand
Heather L
HL
Center for Virology and Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Cullen
Bryan R
BR
D000071478:APOBEC Deaminases; D000071480:APOBEC-3G Deaminase; D000818:Animals; D002460:Cell Line; D003564:Cytidine Deaminase / Q000235:genetics / Q000494:pharmacology; D043525:Cytosine Deaminase / Q000145:classification / Q000235:genetics / Q000494:pharmacology*; D006801:Humans; D015778:Minor Histocompatibility Antigens; D011533:Proviruses / Q000235:genetics / Q000378:metabolism; D011784:Quail; D017393:RNA Editing; D052736:Rous sarcoma virus / Q000187:drug effects* / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology; D014162:Transfection; D014771:Virion / Q000378:metabolism; D019065:Virus Assembly; D014779:Virus Replication / Q000187:drug effects*
D015778:Minor Histocompatibility Antigens; C492906:APOBEC3F protein, human; D043525:Cytosine Deaminase; D000071478:APOBEC Deaminases; D000071480:APOBEC-3G Deaminase; C502889:APOBEC3 proteins, human; C495794:APOBEC3B protein, human; C464924:APOBEC3G protein, human; D003564:Cytidine Deaminase